Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Early Peripheral Blood MRD Status by NGS in Pts With NDMM From a Ph2 Trial of Elo-KRd"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Ben Derman
By
Insights from 2023 ASH Annual Meeting
FEATURING
Ben Derman
Login to view comments.
Click here to Login